Literature DB >> 15545375

Increase of Escherichia coli inoculum doses induces faster innate immune response in primiparous cows.

F Vangroenweghe1, P Rainard, M Paape, L Duchateau, C Burvenich.   

Abstract

The objective of the current study was to evaluate the dynamics of infection and the immunological response to varying numbers of Escherichia coli injected into the mammary glands of primiparous cows during the periparturient period. Primiparous cows have been shown to be more resistant to intramammary E. coli challenge, and an increase of the inoculum dose by 2 log10 units induced a more rapid clinical response and clearance of the organisms. Recognition of lipopolysaccharide (LPS) is a key event in the innate immunity response to gram-negative infection and is mediated by the accessory molecules CD14 and LPS-binding protein (LBP). Primiparous cows were inoculated with 1 x 10(4) (Group A; n=8) or 1 x 10(6) (Group B; n=8) cfu E. coli P4:O32 in their 2 left quarters during the periparturient period. Clinical examination and analysis of blood and milk parameters, including IL-8, complement fragment 5a (C5a), LBP, and soluble CD14 (sCD14), were performed from d -4 to d +3 relative to infection. Primiparous cows in Group B initiated a more rapid clinical response following intramammary infection (IMI), resulting in typical clinical signs and changes in blood and milk parameters approximately 3 h earlier compared with primiparous cows in Group A. Based on average milk production in the noninfected quarters on d +2 postinoculation, all heifers reacted as moderate responders. Distinct differences in the kinetic patterns of rectal temperature, somatic cell count (SCC), IL-8, C5a, LBP, and sCD14 were observed between both groups during the early phase of inflammation. Both C5a and IL-8 increased before cellular influx into the infected glands, followed by increases in sCD14 and LBP. In conclusion, primiparous cows are able to clear an intramammary E. coli infection efficiently. Moreover, increasing the inoculum dose induces a more rapid inflammatory reaction, mainly because of early activation of the innate host immune response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15545375     DOI: 10.3168/jds.S0022-0302(04)73556-0

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  13 in total

1.  Thymol inhibits LPS-stimulated inflammatory response via down-regulation of NF-κB and MAPK signaling pathways in mouse mammary epithelial cells.

Authors:  Dejie Liang; Fengyang Li; Yunhe Fu; Yongguo Cao; Xiaojing Song; Tiancheng Wang; Wei Wang; Mengyao Guo; Ershun Zhou; Depeng Li; Zhengtao Yang; Naisheng Zhang
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

2.  Indirubin Inhibits LPS-Induced Inflammation via TLR4 Abrogation Mediated by the NF-kB and MAPK Signaling Pathways.

Authors:  Jin-Lun Lai; Yu-Hui Liu; Chang Liu; Ming-Pu Qi; Rui-Ning Liu; Xi-Fang Zhu; Qiu-Ge Zhou; Ying-Yu Chen; Ai-Zhen Guo; Chang-Min Hu
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

3.  Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model.

Authors:  Wang Wei; Liang Dejie; Song Xiaojing; Wang Tiancheng; Cao Yongguo; Yang Zhengtao; Zhang Naisheng
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

4.  Repertoire of Escherichia coli agonists sensed by innate immunity receptors of the bovine udder and mammary epithelial cells.

Authors:  Adeline Porcherie; Patricia Cunha; Angelina Trotereau; Perrine Roussel; Florence B Gilbert; Pascal Rainard; Pierre Germon
Journal:  Vet Res       Date:  2012-02-13       Impact factor: 3.683

5.  Effectiveness analysis of resistance and tolerance to infection.

Authors:  Johann C Detilleux
Journal:  Genet Sel Evol       Date:  2011-03-01       Impact factor: 4.297

6.  Variation of inflammatory dynamics and mediators in primiparous cows after intramammary challenge with Escherichia coli.

Authors:  Adel Pezeshki; Philippe Stordeur; Hugues Wallemacq; Frédéric Schynts; Mieke Stevens; Philippe Boutet; Luc J Peelman; Bart De Spiegeleer; Luc Duchateau; Fabrice Bureau; Christian Burvenich
Journal:  Vet Res       Date:  2011-01-24       Impact factor: 3.683

7.  Investigating the contribution of IL-17A and IL-17F to the host response during Escherichia coli mastitis.

Authors:  Perrine Roussel; Patricia Cunha; Adeline Porcherie; Wolfram Petzl; Florence B Gilbert; Céline Riollet; Holm Zerbe; Pascal Rainard; Pierre Germon
Journal:  Vet Res       Date:  2015-06-11       Impact factor: 3.683

8.  A mathematical model to study resistance and tolerance to infection at the animal and population levels: application to E. coli mastitis.

Authors:  Johann C Detilleux
Journal:  Front Genet       Date:  2012-12-14       Impact factor: 4.599

9.  Assessment of the immune capacity of mammary epithelial cells: comparison with mammary tissue after challenge with Escherichia coli.

Authors:  Juliane Günther; Dirk Koczan; Wei Yang; Gerd Nürnberg; Dirk Repsilber; Hans-Joachim Schuberth; Zaneta Park; Nauman Maqbool; Adrian Molenaar; Hans-Martin Seyfert
Journal:  Vet Res       Date:  2009-03-27       Impact factor: 3.683

10.  Acute phase response in two consecutive experimentally induced E. coli intramammary infections in dairy cows.

Authors:  Leena Suojala; Toomas Orro; Hanna Järvinen; Johanna Saatsi; Satu Pyörälä
Journal:  Acta Vet Scand       Date:  2008-06-13       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.